Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ERNA Eterna Therapeutics Inc

0,3493

-0,0197 (-5,34%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Eterna Therapeutics Charts.

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Eterna Therapeutics Charts.

News Eterna Therapeutics Inc

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models
Dienstag 3 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program
Montag 25 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 18 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Montag 18 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
Mittwoch 30 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 29 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
Donnerstag 17 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Freitag 27 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Eterna Therapeutics Inc News-Artikel

Financial Select Sector

BNP Paribas (QX)

Euro vs US Dollar

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen